Trendlines Group Valuation Multiples

Discover Trendlines Group's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Stonebridge Ventures, Quest for Growth, SBI Investment KOREA, Gunosy and more.

Trendlines Group Overview

About Trendlines Group

The Trendlines Group Ltd is engaged in investing in and establishing agrifood tech and medical device companies. The company invests in and builds portfolio companies throughout its entire life cycle. The group's cooperation models include joint ventures, partnerships, co-investments, and the formation of strategic alliances around the world.


Founded

2007

HQ

Israel

Employees

23

Sectors

Financials (FY)

Revenue: $350K
EBITDA: $2M

EV

$64M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Trendlines Group Financials

Trendlines Group reported last fiscal year revenue of $350K and EBITDA of $2M.

In the same fiscal year, Trendlines Group generated ($3M) in gross profit, $2M in EBITDA, and $2M in net income.


Trendlines Group P&L

In the most recent fiscal year, Trendlines Group reported revenue of $350K and EBITDA of $2M.

Trendlines Group is profitable as of last fiscal year, with gross margin of (714%), EBITDA margin of 638%, and net margin of 548%.

See analyst estimates for Trendlines Group
Last FY202320242025202620272028
Revenue$350K$4M$2M$350K
Gross Profit($3M)($1M)($2M)($3M)
Gross Margin(714%)(26%)(100%)(714%)
EBITDA$2M($34M)($9M)$2M
EBITDA Margin638%(755%)(540%)638%
EBIT Margin22%(763%)(623%)22%
Net Profit$2M($34M)($9M)$2M
Net Margin548%(756%)(548%)548%

Financial data powered by Morningstar, Inc.

Trendlines Group Stock Performance

Trendlines Group has current market cap of $64M, and enterprise value of $64M.


Trendlines Group's stock price is $0.04.

See more trading valuation data for Trendlines Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$64M$64M-0.0%---$0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Trendlines Group Valuation Multiples

Trendlines Group trades at 182.8x EV/Revenue multiple, and 28.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Trendlines Group

Trendlines Group Financial Valuation Multiples

As of August 14, 2026, Trendlines Group has market cap of $64M and EV of $64M.

Trendlines Group has a P/E ratio of 33.2x.

Last FY202320242025202620272028
EV/Revenue182.8x14.2x37.2x182.8x
EV/EBITDA28.6x(1.9x)(6.9x)28.6x
EV/EBITn/m(1.9x)(6.0x)n/m
EV/Gross Profit(25.6x)(55.6x)(37.1x)(25.6x)
P/E33.2x(1.9x)(6.8x)33.2x
EV/FCF(7.1x)(10.0x)(7.2x)(7.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Trendlines Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Trendlines Group Margins & Growth Rates

In the most recent fiscal year, Trendlines Group reported gross margin of (714%), EBITDA margin of 638%, and net margin of 548%.

See estimated margins and future growth rates for Trendlines Group

Trendlines Group Margins

Last FY20242025202720282029
Gross Margin(714%)(100%)(714%)
EBITDA Margin638%(540%)638%
EBIT Margin22%(623%)22%
Net Margin548%(548%)548%
FCF Margin(2580%)(516%)(2580%)

Trendlines Group Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(62%)(80%)
Gross Profit Growth50%45%
EBITDA Growth(73%)(124%)
EBIT Growth(69%)(101%)
Net Profit Growth(72%)(120%)
FCF Growth38%2%

Data powered by FactSet, Inc. and Morningstar, Inc.

Trendlines Group Operational KPIs

Trendlines Group's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $-0.1M for the same period.

Access forward-looking KPIs for Trendlines Group
Last FY202320242025202620272028
Revenue per Employee$0.0M---
Opex per Employee$-0.1M---
S&M Expenses to Revenue54%5%10%54%
G&A Expenses to Revenue1045%63%165%1045%
R&D Expenses to Revenue0%38%28%0%
Opex to Revenue(737%)737%522%(737%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Trendlines Group Competitors

Trendlines Group competitors include Stonebridge Ventures, Quest for Growth, SBI Investment KOREA, Gunosy, Luzon Credit and Finance, Company K Partners, Alpha, Brookfield Glb Infr Secs, LB Investment and Atinum Investment.

Most Trendlines Group public comparables operate across PE & VC.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Stonebridge Ventures2.5x-4.5x-
Quest for Growth(37.4x)---
SBI Investment KOREA1.2x-3.6x-
Gunosy0.7x0.7x14.3x-
Luzon Credit and Finance----
Company K Partners4.5x-9.4x-
Alpha0.3x0.3x3.8x-
Brookfield Glb Infr Secs8.5x---

This data is available for Pro users. Sign up to see all Trendlines Group competitors and their valuation data.

Start Free Trial

Trendlines Group VC Funding History

Before going public, Trendlines Group raised $3M in total equity funding, across 3 rounds.


Trendlines Group Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Feb-15Seed-$1M--
Apr-14Angel-$1M--
Jun-13Pre-seed-$900K--

Investments by Trendlines Group

Trendlines Group has invested in 31 companies to date.

Latest investment by Trendlines Group was on November 11th 2025. Trendlines Group invested in IBI-Ag in their $4M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Trendlines Group

IBI-Ag
IBI-Ag
Celleste Bio
Peptobiotics
Description
IBI-Ag is a Rehovot-based biotechnology firm developing bioinsecticides using RNA interference technology. Founded in 2015, the company targets crop pests like aphids and whiteflies with environmentally safe solutions produced via fermentation. Its lead product, IBI-100, controls tomato pests in greenhouses, reducing chemical use by 90 percent. IBI-Ag collaborates with agrochemical giants like BASF and serves farmers in Israel, Europe, and North America, emphasizing cost-effective, selective insect control.
IBI-Ag is a Rehovot-based biotechnology firm developing bioinsecticides using RNA interference technology. Founded in 2015, the company targets crop pests like aphids and whiteflies with environmentally safe solutions produced via fermentation. Its lead product, IBI-100, controls tomato pests in greenhouses, reducing chemical use by 90 percent. IBI-Ag collaborates with agrochemical giants like BASF and serves farmers in Israel, Europe, and North America, emphasizing cost-effective, selective insect control.
Celleste Bio produces cocoa butter and flavor compounds through precision fermentation of plant cell cultures, bypassing cocoa farming. Its bioreactor process yields 1,000 tons annually of cocoa alternatives matching natural profiles. London-headquartered since 2020, the company supplies to Barry Callebaut and Nestlé for chocolate formulations. Celleste Bio reduces water usage by 90 percent versus traditional agriculture. The firm licenses strains from UC Berkeley for lipid optimization.
Peptobiotics is a Copenhagen-headquartered synbio startup engineering peptide-based alternatives to antibiotics for livestock disease prevention. Its platform produces antimicrobial peptides that promote animal growth and combat pathogens without fostering resistance. The technology targets poultry and swine sectors to improve feed efficiency and reduce antibiotic use. Peptobiotics advances sustainable protein production through partnerships with European feed mills and veterinary firms.
HQ CountryIsraelIsraelIsraelSingapore
HQ City
Ness Ziona
Ness Ziona
Misgav
Singapore
Deal Date11 Nov 202513 Feb 20255 Dec 20249 Apr 2024
RoundSeries ASeries ASeedSeries A
Raised$4M$6M$5M$6M
InvestorsCorteva Catalyst; Iron Nation; Consensus Business Group; Trendlines GroupCorteva; Iron Nation; Consensus Business Group; Trendlines GroupSnackFutures; Supply Change Capital; Barrel Ventures; Consensus Business Group; Trendlines Group; Regba GroupFarmabase; The Yield Lab Asia Pacific; Hatch Blue Ltd; Seeds Capital; Ponderosa Ventures; Seventure Partners; GrainCorp Ventures; Trendlines Group
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Trendlines Group investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Trendlines Group

When was Trendlines Group founded?Trendlines Group was founded in 2007.
Where is Trendlines Group headquartered?Trendlines Group is headquartered in Israel.
How many employees does Trendlines Group have?As of today, Trendlines Group has over 23 employees.
Is Trendlines Group publicly listed?Yes, Trendlines Group is a public company listed on Singapore Exchange.
What is the stock symbol of Trendlines Group?Trendlines Group trades under 42T ticker.
When did Trendlines Group go public?Trendlines Group went public in 2015.
Who are competitors of Trendlines Group?Trendlines Group main competitors include Stonebridge Ventures, Quest for Growth, SBI Investment KOREA, Gunosy, Luzon Credit and Finance, Company K Partners, Alpha, Brookfield Glb Infr Secs, LB Investment, Atinum Investment.
What is the current market cap of Trendlines Group?Trendlines Group's current market cap is $64M.
What is the current revenue of Trendlines Group?Trendlines Group's last fiscal year revenue is $350K.
What is the current EV/Revenue multiple of Trendlines Group?Current revenue multiple of Trendlines Group is 182.8x.
Is Trendlines Group profitable?No, Trendlines Group is not profitable.
How many companies Trendlines Group has acquired to date?Trendlines Group hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Trendlines Group has invested to date?As of August 2026, Trendlines Group has invested in 31 companies.

See public comps similar to Trendlines Group

Lists including Trendlines Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial